-transparent.png){kind=logo}
The effect of ciamexone on lymphocytic thyroiditis and insulin-dependent diabetes mellitus in the BB/Wor rat. 1990
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
Department of Medicine, University of Massachusetts Medical School, Worcester 01655.
Previous studies have suggested that ciamexone, a 2-cyan-aziridine derivative, is a selective immunomodulatory agent with potential therapeutic application in a variety of autoimmune diseases. In the present study, the effects of ciamexone on autoimmune lymphocytic thyroiditis and diabetes mellitus were studied in the BB rat. The data suggest that, in this animal model, ciamexone does not affect the frequency of autoimmune diabetes or lymphocytic thyroiditis nor does it affect the serum TSH or T4 concentrations.
Related Publications
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
July 1990,
Acta endocrinologica,
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
June 1998,
European journal of endocrinology,
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
May 1991,
Diabetologia,
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
March 1988,
Endocrinology,
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
August 1987,
Diabetes research (Edinburgh, Scotland),
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
January 1991,
Autoimmunity,
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
January 1992,
Autoimmunity,
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
January 1986,
Journal of immunopharmacology,
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
January 2000,
Annals of clinical and laboratory science,
S Abend, and
J Cormier, and
M C Appel, and
W Lueprasitsakul, and
S Alex, and
J P Mordes, and
K H Usadel, and
E S Handler, and
A A Rossini, and
L E Braverman
January 1997,
Life sciences,
